AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)

Loading prices

Sg Finance Yahoo

Published November 8, 2026

Weekly Roundup on the Cannabis Sector & Psychedelic Sector - Yahoo Finance Singapore

Read the full story at Sg Finance Yahoo

Psychedelic Sector Bright Minds Biosciences Received Partial FDA Clinical Hold on BMB-101 Phase 2 Epilepsy Trial Optimi Health Established.

Post on X

Share this story

Surfaced by this Google Alert

Psychedelics